How Checkpoint Inhibitors Are Impacting Treatment Algorithms In mCRC

How Checkpoint Inhibitors Are Impacting Treatment Algorithms In mCRC

obr

1 year
40 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Howard Hochster, MD, Associate Director for Clinical Research, Rutgers Cancer institute of New jersey, Director of Oncology Research, RWJBarnabas Health discusses, How Checkpoint Inhibitors Are Impacting Treatment Algorithms In mCRC. At The 2019 Gastrointestinal Cancers Symposium In San Francisco, CA On Jan 17, 2019. http://obroncology.com
Up Next Autoplay